NEW YORK, July 10, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical technology company focused on aesthetic technologies with a strong emphasis on product development and innovation, today announced that Professor Robert Langer, Chairman of its Scientific Advisory Board, presented initial data highlighting the benefits of the company’s proprietary SilkSurface® technology at the recent, 13th […]

Second manufacturing facility in Costa Rica has received certification and begun shipping units to Europe and around the world. This new site, in combination with the company’s existing facility, extends manufacturing capacity by 4X and enables the company to expand its distribution capability. NEW YORK, NY (PRWEB) JUNE 02, 2017 Establishment Labs, a global medical […]

The funding will be used primarily to support the international launch of Motiva Implants® and Puregraft® in new markets NEW YORK, NY (PRWEB) APRIL 17, 2017 Establishment Labs, a global medical device company focused on breast surgery technologies with a strong emphasis on product development and innovation, announced today that it has closed an $18 […]

Investment of $16.5M in the new manufacturing facility will support its growing international market presence NEW YORK, NY (PRWEB) DECEMBER 15, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced today the opening of a state of the art silicone medical […]

An exclusive international distribution transaction marries advanced breast implants and autologous fat transfers NEW YORK, NY (PRWEB) SEPTEMBER 14, 2016 Establishment Labs, a global medical device company focused on next-generation breast implants and other innovative medical device technologies, announced today that it has entered into an exclusive agreement to distribute Puregraft’s® line of autologous fat […]